Nyxol Eye Drops $Ocuphire Pharma(OCUP)$ $3.92
PDUFA date of September 28, 2023.
网页链接{Ocuphire Pharma Announces Financial Results for Second Quarter 2...查看全文
美股滚雪球2022-08-16 15:56
$头脑风暴细胞治疗(BCLI)$ 治疗渐冻症的三期失败了,后来又修正了一些数据,现在看到$Amylyx(AMLX)$ 有望获批,以及$Biogen制药(BIIB)$ 的药物获得优先评审,BCLI又开始准备提交BLA查看全文
chuminhua2021-03-05 23:50
3月3日,BrainStorm称,FDA已经通知他们,需要更多的数据,才有望获得其ALS治疗NurOwn的批准,但与此同时,他们仍在宣传疗效的 "明确信号”,且并不排除申请的可能性。一周多后,FDA在一份最不寻常的声明中澄清。
FDA的声明提供了一组不同于该公司去年11月公开介绍的疗效数字,并排除了任...查看全文
chuminhua2021-02-23 23:25
2月22日,BrainStorm Cell Therapeutics表示,FDA认为,该公司在研细胞疗法NurOwn的III期研究中没有足够的 "实质性证据 "来支持肌萎缩侧索硬化症(ALS)的上市申请。据BrainStorm,该机构建议其提供额外的临床数据以支持申请,虽然该建议 "不排除[我们]继续进行......提交",但该...查看全文
$Brainstorm Cell Therapeutics Inc.(BCLI)$ S-3 - Registration statement under Securities Act of 1933 Filed: 2018-06-08 AccNo: 0001144204-18-033428 Size: 208 KB 网页链接
$Brainstorm Cell Therapeutics Inc.(BCLI)$ 424B3 - Prospectus [Rule 424(b)(3)] Filed: 2018-06-07 AccNo: 0001144204-18-033160 Size: 198 KB 网页链接
$Brainstorm Cell Therapeutics Inc.(BCLI)$ 8-K - Current report Filed: 2018-06-07 AccNo: 0001144204-18-033158 Size: 186 KBItem 1.01: Entry into a Material Definitive AgreementItem 3.02: Unregistered Sales of Equity SecuritiesItem 9.01: Financial Statements and Exhibits 网页链接
$Brainstorm Cell Therapeutics Inc.(BCLI)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2018-05-14 AccNo: 0001144204-18-027804 Size: 1 MB 网页链接
$Brainstorm Cell Therapeutics Inc.(BCLI)$ 美东时间 2018-05-14 盘前 披露财报,预期EPS -0.14 网页链接
$Brainstorm Cell Therapeutics Inc.(BCLI)$ 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] Filed: 2018-03-08 AccNo: 0001144204-18-013470 Size: 10 MB 网页链接
$Brainstorm Cell Therapeutics Inc.(BCLI)$ 美东时间 2018-03-08 盘前 披露财报,预期EPS -0.09 网页链接
$Brainstorm Cell Therapeutics Inc.(BCLI)$ 8-K - Current report Filed: 2018-02-05 AccNo: 0001144204-18-005749 Size: 17 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers...
$Brainstorm Cell Therapeutics Inc.(BCLI)$ 8-K - Current report Filed: 2018-01-04 AccNo: 0001144204-18-000714 Size: 16 KBItem 8.01: Other Events 网页链接
$Brainstorm Cell Therapeutics Inc.(BCLI)$ 8-K - Current report Filed: 2017-11-13 AccNo: 0001144204-17-058394 Size: 26 KBItem 5.07: Submission of Matters to a Vote of Security Holders 网页链接